- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 5/083 - Tripeptides the side chain of the first amino acid being acyclic, e.g. Gly, Ala
Patent holdings for IPC class C07K 5/083
Total number of patents in this class: 630
10-year publication summary
|
80
|
64
|
64
|
54
|
56
|
31
|
45
|
57
|
36
|
14
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
20 |
| ImmunoGen, Inc. | 405 |
14 |
| Onyx Therapeutics, Inc. | 71 |
10 |
| Biohaven Therapeutics Ltd. | 88 |
10 |
| Genentech, Inc. | 3742 |
9 |
| Agency for Science, Technology and Research | 3512 |
8 |
| Kyoto University | 2732 |
8 |
| Arvinas Operations, Inc. | 165 |
8 |
| Merck Sharp & Dohme LLC | 3689 |
8 |
| Hoffmann-La Roche Inc. | 3060 |
7 |
| Yafei Shanghai Biolog Medicine Science & Technology Co., Ltd. | 13 |
7 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 1906 |
6 |
| Gilead Pharmasset LLC | 43 |
6 |
| On Target Laboratories, LLC | 37 |
6 |
| viDA Therapeutics Inc. | 16 |
6 |
| Novartis AG | 11238 |
5 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
5 |
| The Johns Hopkins University | 5377 |
5 |
| Ajinomoto Co., Inc. | 2337 |
5 |
| Purdue Research Foundation | 3277 |
5 |
| Other owners | 472 |